MDLZ
28
4
MO
57
4
AIV
48
4
EQT
51
-5
CNP
55
3
MU
79
3
GS
78
2
ALLE
48
2
DHI
40
3
MHK
50
2
COST
53
5
FITB
72
2
EQR
47
2
GWW
65
3
GRMN
40
3
BK
77
2
IBM
67
2
ADT
48
2
F
58
2
IFF
62
5
MDLZ
28
4
MO
57
4
AIV
48
4
EQT
51
-5
CNP
55
3
MU
79
3
GS
78
2
ALLE
48
2
DHI
40
3
MHK
50
2
COST
53
5
FITB
72
2
EQR
47
2
GWW
65
3
GRMN
40
3
BK
77
2
IBM
67
2
ADT
48
2
F
58
2
IFF
62
5
Financhill
Back

Berkshire Hathaway, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
45

BRK.A
Berkshire Hathaway, Inc.

Last Price:
$749,660.40
Seasonality Move:
7.44%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
45
Berkshire Hathaway, Inc. (BRK.A) is a Sell

Is Berkshire Hathaway, Inc. a Buy, Sell or Hold?

  • The current Berkshire Hathaway, Inc. [BRK.A] share price is $751,245.04. The Score for BRK.A is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRK.A Stock Price Chart

What is Berkshire Hathaway, Inc.'s stock price today?

  • The Berkshire Hathaway, Inc. share price today is $751,245.04
    The current trend is moderately bearish and BRK.A is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 212.21 Buy
Relative Strength Index (14 RSI): 50.54 Buy
Chaikin Money Flow: 67 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (753654.61 - 753670.61) Sell
Bollinger Bands (100): (741012.89 - 741044.89) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 752156.33 Sell
20-day SMA: 752657.79 Sell
50-day SMA: 746119.7 Buy
200-day SMA: 747475.1 Buy
8-day EMA: 750673.72 Buy
20-day EMA: 750955.32 Buy
50-day EMA: 748140.9 Buy
200-day EMA: 735342.56 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Berkshire Hathaway, Inc. Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $299.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,675.77 per share, and an increase next year of $3,470.08 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Berkshire Hathaway, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):